RGS.AX
Price:
$0.012
Market Cap:
$3.68M
Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.
Industry
Biotechnology
IPO Date
2013-09-19
Stock Exchange
ASX
Ticker
RGS.AX
According to Regeneus Ltd’s latest financial reports and current stock price. The company's current ROE is 455.81%. This represents a change of 710.50% compared to the average of 56.24% of the last 4 quarters.
The mean historical ROE of Regeneus Ltd over the last ten years is 237.44%. The current 455.81% ROE has changed 91.97% with respect to the historical average. Over the past ten years (40 quarters), RGS.AX's ROE was at its highest in in the December 2019 quarter at 326.23%. The ROE was at its lowest in in the June 2022 quarter at -157.64%.
Average
237.44%
Median
-17.16%
Minimum
-407.74%
Maximum
2.93%
Discovering the peaks and valleys of Regeneus Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.15%
Maximum Annual ROE = 2.93%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -407.74%
| Year | ROE | Change |
|---|---|---|
| 2023 | 92.94% | -122.79% |
| 2022 | -407.74% | -885.08% |
| 2021 | 51.94% | -98.23% |
| 2020 | 2.93% | 3.15% |
| 2019 | 90.09% | -150.77% |
| 2018 | -177.45% | -539.46% |
| 2017 | 40.38% | -154.06% |
| 2016 | -74.69% | -6.48% |
| 2015 | -79.86% | -11.80% |
| 2014 | -90.55% | -Infinity% |
The current ROE of Regeneus Ltd (RGS.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-87.62%
5-year avg
551.32%
10-year avg
237.44%
Regeneus Ltd’s ROE is greater than Visioneering Technologies, Inc. (-57.27%), greater than Allegra Medical Technologies Limited (-1152.11%), greater than Hexima Limited (-52.59%), greater than Uscom Limited (-358.43%), greater than Universal Biosensors, Inc. (-118.58%), less than Bod Science Limited (213.00%), greater than Stemcell United Limited (-82.38%), less than Freedom Care Group Holdings Ltd. (30.96%), greater than Exopharm Limited (-110.25%), greater than Medibio Limited (-7.84%),
| Company | ROE | Market cap |
|---|---|---|
| -57.27% | $3.70M | |
| -1152.11% | $3.47M | |
| -52.59% | $2.17M | |
| -358.43% | $3.12M | |
| -118.58% | $4.17M | |
| 213.00% | $4.26M | |
| -82.38% | $3.85M | |
| 30.96% | $4.01M | |
| -110.25% | $1.93M | |
| -7.84% | $4.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regeneus Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regeneus Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Regeneus Ltd's ROE?
How is the ROE calculated for Regeneus Ltd (RGS.AX)?
What is the highest ROE for Regeneus Ltd (RGS.AX)?
What is the 3-year average ROE for Regeneus Ltd (RGS.AX)?
What is the 5-year average ROE for Regeneus Ltd (RGS.AX)?
How does the current ROE for Regeneus Ltd (RGS.AX) compare to its historical average?